G6PD deficiency is one of the most common enzyme deficiencies worldwide, affecting an estimated 400 million people. The prevalence is particularly high in regions where malaria is or was endemic, such as Africa, the Mediterranean, and Southeast Asia. In these areas, the genetic mutation may provide some protection against malaria, offering a potential evolutionary advantage.
